May 06, 2020
Bausch Health And Alfasigma Announce Resolution Of XIFAXAN® Intellectual Property Litigation
Mar 23, 2020
Sandoz acquires US distribution rights to two key hospital injectable medicines, reinforcing strategic focus on key growth segment
Feb 04, 2020
United Therapeutics Defeats Preliminary Injunction Motion In Litigation With Sandoz And RareGen
Oct 01, 2019
Bausch Health Files Lawsuit Against Sandoz For Infringement Of Patents Protecting XIFAXAN® 550 mg Tablets
Sep 24, 2019
FDA announces voluntary recall of Sandoz ranitidine capsules following detection of an impurity
Sep 23, 2019
Sandoz Inc. Issues Voluntary Recall of Ranitidine Hydrochloride Capsules 150mg and 300mg Due to an Elevated Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA), in the Product
Aug 29, 2019
Sandoz Inc. voluntarily recalls Losartan Potassium and Ezetimibe in prescription drug bottles in the U.S. due to failure to meet child-resistant closure requirements
Jul 09, 2019
Sandoz extends SYMJEPI(TM) (epinephrine) Injection launch to US pharmacies to help improve patient access to life-saving medicine
Jun 27, 2019
Sandoz enters agreement with Kit Check to track, automate restocking of products in U.S. hospitals
Feb 20, 2019
Indivior Announces Launch of SUBOXONE® (buprenorphine and naloxone) Sublingual Film Authorized Generic
Feb 19, 2019
Sandoz Inc. launches authorized generic version of buprenorphine and naloxone sublingual film
Jan 16, 2019
Sandoz Inc. launches SYMJEPI(TM) (epinephrine) in the US
Nov 08, 2018
Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Losartan Potassium and Hydrochlorothiazide Due to the Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine) Impurity Found in the Active Pharmaceutical Ingredient (API)
Oct 30, 2018
Global Injection Pens Market, 2018-2025 Featuring Key Players - Owen Mumford, GlaxoSmithKline, Eli Lilly and Co, Mylan, AstraZeneca, Novo Nordisk, Sanofi and Sandoz
Jul 06, 2018
Sandoz Inc. and its affiliate, Novartis Pharmaceuticals Corporation, voluntarily recall select blister packages of products in the U.S. due to packaging requirements for child resistance
Apr 30, 2018
$20 Million Class Action Settlement has been Reached for Purchasers of Solodyn®
Apr 05, 2018
If You Purchased Solodyn® and/or Its Generic Equivalent You Could Get Money from a Class Action Lawsuit Settlement
Feb 13, 2018
Sandoz announces US FDA approval and launch of Glatopa® 40 mg/mL three times-a-week generic option for relapsing forms of multiple sclerosis